AHA warns about CVD risk of some hormonal therapies for cancer
The potential danger for patients with breast or prostate cancer must not be overlooked, expert says
Patients receiving hormonal therapy to treat breast or prostate cancer may be increasing the risk of dying from heart disease, the American Heart Association advises in a new scientific statement.
In a review of the available research, the statement authors find that patients receiving hormone therapy need to be monitored closely for heart risks, and the longer the treatment lasts, the greater the risk of CVD.
"We as clinicians — oncologists, cardiologists and primary